221 related articles for article (PubMed ID: 25287419)
41. Early Life Growth Trajectories in Cystic Fibrosis are Associated with Pulmonary Function at Age 6 Years.
Sanders DB; Fink A; Mayer-Hamblett N; Schechter MS; Sawicki GS; Rosenfeld M; Flume PA; Morgan WJ
J Pediatr; 2015 Nov; 167(5):1081-8.e1. PubMed ID: 26340874
[TBL] [Abstract][Full Text] [Related]
42. Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis.
Rowe SM; Heltshe SL; Gonska T; Donaldson SH; Borowitz D; Gelfond D; Sagel SD; Khan U; Mayer-Hamblett N; Van Dalfsen JM; Joseloff E; Ramsey BW;
Am J Respir Crit Care Med; 2014 Jul; 190(2):175-84. PubMed ID: 24927234
[TBL] [Abstract][Full Text] [Related]
43. Accrual of Bone Mass in Children and Adolescents With Cystic Fibrosis.
Sharma S; Jaksic M; Fenwick S; Byrnes C; Cundy T
J Clin Endocrinol Metab; 2017 May; 102(5):1734-1739. PubMed ID: 28323913
[TBL] [Abstract][Full Text] [Related]
44. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
45. Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infection.
Pittman JE; Noah H; Calloway HE; Davis SD; Leigh MW; Drumm M; Sagel SD; Accurso FJ; Knowles MR; Sontag MK
PLoS One; 2017; 12(5):e0177215. PubMed ID: 28505188
[TBL] [Abstract][Full Text] [Related]
46. Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D-CFTR mutation and preserved spirometry: a randomised controlled trial.
Davies J; Sheridan H; Bell N; Cunningham S; Davis SD; Elborn JS; Milla CE; Starner TD; Weiner DJ; Lee PS; Ratjen F
Lancet Respir Med; 2013 Oct; 1(8):630-638. PubMed ID: 24461666
[TBL] [Abstract][Full Text] [Related]
47. Chloride Conductance, Nasal Potential Difference and Cystic Fibrosis Pathophysiology.
Procianoy EDFA; de Abreu E Silva FA; Maróstica PJC; Quinton PM
Lung; 2020 Feb; 198(1):151-156. PubMed ID: 31734731
[TBL] [Abstract][Full Text] [Related]
48. Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor.
Heltshe SL; Mayer-Hamblett N; Burns JL; Khan U; Baines A; Ramsey BW; Rowe SM;
Clin Infect Dis; 2015 Mar; 60(5):703-12. PubMed ID: 25425629
[TBL] [Abstract][Full Text] [Related]
49. Modeling cystic fibrosis disease progression in patients with the rare CFTR mutation P67L.
MacKenzie IER; Paquette V; Gosse F; George S; Chappe F; Chappe V
J Cyst Fibros; 2017 May; 16(3):335-341. PubMed ID: 28392015
[TBL] [Abstract][Full Text] [Related]
50. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
[TBL] [Abstract][Full Text] [Related]
51. Evidence for a causal relationship between early exocrine pancreatic disease and cystic fibrosis-related diabetes: a Mendelian randomization study.
Soave D; Miller MR; Keenan K; Li W; Gong J; Ip W; Accurso F; Sun L; Rommens JM; Sontag M; Durie PR; Strug LJ
Diabetes; 2014 Jun; 63(6):2114-9. PubMed ID: 24550193
[TBL] [Abstract][Full Text] [Related]
52. Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population.
Polineni D; Piccorelli AV; Hannah WB; Dalrymple SN; Pace RG; Durie PR; Ling SC; Knowles MR; Stonebraker JR
PLoS One; 2018; 13(10):e0205257. PubMed ID: 30307979
[TBL] [Abstract][Full Text] [Related]
53. Body mass index and additional risk factors for cancer in adults with cystic fibrosis.
Knotts RM; Jin Z; Doyle JB; Keating C; DiMango E; Abrams JA
Cancer Causes Control; 2022 Dec; 33(12):1445-1451. PubMed ID: 36178608
[TBL] [Abstract][Full Text] [Related]
54. Human Epididymis Protein 4: A Novel Serum Inflammatory Biomarker in Cystic Fibrosis.
Nagy B; Nagy B; Fila L; Clarke LA; Gönczy F; Bede O; Nagy D; Újhelyi R; Szabó Á; Anghelyi A; Major M; Bene Z; Fejes Z; Antal-Szalmás P; Bhattoa HP; Balla G; Kappelmayer J; Amaral MD; Macek M; Balogh I
Chest; 2016 Sep; 150(3):661-72. PubMed ID: 27105680
[TBL] [Abstract][Full Text] [Related]
55. An Observational Study of Outcomes and Tolerances in Patients with Cystic Fibrosis Initiated on Lumacaftor/Ivacaftor.
Jennings MT; Dezube R; Paranjape S; West NE; Hong G; Braun A; Grant J; Merlo CA; Lechtzin N
Ann Am Thorac Soc; 2017 Nov; 14(11):1662-1666. PubMed ID: 28406713
[TBL] [Abstract][Full Text] [Related]
56. Comparison of radiographic and clinical characteristics of low-risk and high-risk cystic fibrosis genotypes.
Ferril GR; Nick JA; Getz AE; Barham HP; Saavedra MT; Taylor-Cousar JL; Nichols DP; Curran-Everett D; Kingdom TT; Ramakrishnan VR
Int Forum Allergy Rhinol; 2014 Nov; 4(11):915-20. PubMed ID: 25224556
[TBL] [Abstract][Full Text] [Related]
57. Impact of newborn screening on outcomes and social inequalities in cystic fibrosis: a UK CF registry-based study.
Schlüter DK; Southern KW; Dryden C; Diggle P; Taylor-Robinson D
Thorax; 2020 Feb; 75(2):123-131. PubMed ID: 31771956
[TBL] [Abstract][Full Text] [Related]
58. Association between genetically determined pancreatic status and lung disease in adult cystic fibrosis patients.
Loubières Y; Grenet D; Simon-Bouy B; Medioni J; Landais P; Férec C; Stern M
Chest; 2002 Jan; 121(1):73-80. PubMed ID: 11796434
[TBL] [Abstract][Full Text] [Related]
59. Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French CF registry.
Vongthilath R; Richaud Thiriez B; Dehillotte C; Lemonnier L; Guillien A; Degano B; Dalphin ML; Dalphin JC; Plésiat P
PLoS One; 2019; 14(1):e0210201. PubMed ID: 30620748
[TBL] [Abstract][Full Text] [Related]
60. Physiological response during activity programs using Wii-based video games in patients with cystic fibrosis (CF).
del Corral T; Percegona J; Seborga M; Rabinovich RA; Vilaró J
J Cyst Fibros; 2014 Dec; 13(6):706-11. PubMed ID: 24935613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
